Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Electromed Earnings Spark a 25% Increase in Its Share Price

Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. Develo...

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....

Welcome to the Zombie-land Of Investing - Part II

In Part I of this research post, we highlight how the ES and Gold reacted 24+ months prior to the 2007-08 market peak and subsequent collapse in 2008-09. The point we were trying to push out to our followers was that the current US stock market indexes are acting in a very...

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. Clinical-stage...

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Central Banks Fire Bazooka at Coronavirus. Will Gold Rally?

The new coronavirus has already infected the global economy. The global lockdown means that recession is inevitable. The central banks all over the world have stepped in, including the Fed, cutting interest rates and pumping liquidity into the system. We invite you thus ...

Nicola Mining advancing consolidated, high-grade British Columbia copper asset

Nicola Mining is focused on identifying, acquiring and exploring several types of mineral property interests. The British Columbia-based resource company counts a mill and tailing facility, a fully-permitted silver mine, an exciting copper project and active rock q...

Vanstar Mining Resources: a gold exploration company focused on northern Quebec.

Vanstar Mining Resources is a Montreal-based gold exploration firm with properties located in Northern Quebec at various stages of development. That includes the company’s flagship Nelligan Gold Project and its increasing gold resource, where exploration w...
1 2 3 4 5 6 7 8 9 10 ...